New research in nuclear medicine and molecular imaging has led to breakthroughs in cancer diagnosis and treatment. Multispectral optoacoustic tomography detects blood flow problems before reconstructive surgery, while FAPI PET imaging assesses liver fibrosis in people with metabolic dysfunction–associated steatotic liver disease.
The partnership aims to strengthen quantitative molecular imaging by promoting harmonized approaches to image acquisition, reconstruction, and analysis. By developing and implementing shared standards, the organizations seek to improve the accuracy and consistency of quantitative imaging results.
A retrospective cohort study found that only 24 of 2,924 urgent care lumbar spine X-rays for uncomplicated low back pain were followed by emergency department advanced imaging within 30 days. Urgent care X-rays used about one-quarter of the imaging resources of emergency department CT or MRI.
A study published in Nature Medicine reveals that artificial intelligence can identify associations between human movement patterns and 1,887 health measures spanning 18 body systems. Movement analysis provided independent predictive information beyond traditional health assessments.
The National MS Society is launching a funding opportunity to support innovative screening technologies for early MS detection. The goal is to accelerate progress in identifying individuals at risk of MS, ultimately reducing time to diagnosis and improving long-term outcomes.
Research in PSMA radioligand distribution reveals increased radiation exposure to healthy tissues. A new PET tracer detects kidney fibrosis, while EGFR-targeted radiotheranostics show promise against liver cancer. Clinical trials evaluate CXCR4-targeted therapy for acute leukemia and patient guidance for PSMA therapy.
Researchers developed an ultrafast all-optical biomimetic encoder for spiking neural networks, achieving high-throughput computation and precise fiber-compatible encoding. The system reaches 94.1% classification accuracy for handwritten digit recognition and demonstrates scalability for diverse real-life signals.
A recent study published in The Journal of Nuclear Medicine found that local radiologists and nuclear medicine physicians can reliably interpret amyloid PET scans with high agreement, showing that visual reads performed in community settings are highly reliable for diagnosing and managing Alzheimer's disease. The study utilized data fr...
Artificial intelligence holds promise in osteosarcoma imaging, supporting decision-making with tools for radiographic triage, tumor segmentation, and risk prediction. However, reliability and reproducibility are crucial concerns, requiring independent external testing and evaluation.
Researchers have made significant advancements in nuclear medicine, improving treatment outcomes for prostate cancer, detecting cancer recurrence, and predicting treatment outcomes. Studies have shown that combining imaging methods, such as PET/CT and MRI, can improve detection of prostate cancer, while diagnostic scans may predict tum...
A study by National Institutes for Quantum Science and Technology researchers found that faster buildup of abnormal tau protein in the brain is linked to faster symptom worsening in progressive supranuclear palsy, a rare neurodegenerative disease. The discovery could help researchers objectively measure disease progression and accelera...
A metalens photoacoustic microscope can switch focus with voltage, enabling deeper imaging of biological structures. The system achieves an axial imaging range of approximately 1.2 mm and high spatial resolutions for visualizing microscopic vascular structures.
Researchers evaluated PET imaging with radiolabeled trastuzumab deruxtecan and targeted alpha therapy against HER2-positive cancer cells, revealing promising results in tracking therapy accumulation and suppressing tumor growth. PET imaging also linked metabolic patterns to pancreatic tumor outcomes and identified potential distant met...
The new standard/guideline provides evidence-based recommendations for conducting and interpreting lung imaging, incorporating recent technological advances. It aims to promote comprehensive patient assessment and improve diagnostic accuracy, reproducibility, and patient outcomes.
A Lehigh-led team is developing an AI platform called UniBrain to simplify brain imaging analysis, reducing the time and expertise required. The platform aims to unify image preprocessing and downstream brain network analysis, integrating information from multiple imaging modalities.
A new PET imaging approach using carbonic anhydrase IX (CAIX) detected 97.9% of lesions in clear cell renal cell carcinoma (ccRCC), outperforming ¹⁸F-FDG PET/CT. The approach improved patient-level diagnostic accuracy in ccRCC, leading to changes in clinical management or disease stage in 30.9% of patients.
Researchers developed a scalable photonic crystal scintillator that improves light extraction efficiency and X-ray imaging signal-to-noise ratio. The approach increased light output by 4.64-fold and maintained spatial resolution better than 25 μm.
Researchers developed a next-generation PET/CT scanner that produces diagnostic-quality images in as little as one minute, surpassing the performance of conventional scanners. The study showed that even 90% shorter scans maintained high image quality, making it a game-changer for cancer diagnosis and treatment.
Recent studies published in The Journal of Nuclear Medicine investigate novel radiohybrid ligands for prostate cancer therapy, AI models predicting prostate cancer survival, and PET tracers for meningioma treatment. These advancements show promise for personalized medicine and improved patient outcomes.
Early assessment with 68Ga-HER2 PET/CT during neoadjuvant therapy can predict pathologic complete response in patients with HER2-positive breast cancer, with a 85% success rate for those with tumor uptake decrease of at least 61%. This finding has implications for timely consideration of alternative treatment strategies or surgery.
Researchers developed new imaging approaches and tracers to target prostate cancer, breast cancer, and other conditions. These methods showed promising results in improving detection and treatment outcomes.
Nuclear medicine is experiencing rapid growth with over 50 million procedures performed worldwide each year. EANM'26 will present the latest advances in nuclear medicine, molecular imaging, and radiopharmaceuticals, including theranostics and next-generation imaging technology.
A new study finds that PSMA PET/CT-guided targeted biopsy can detect clinically significant prostate cancer in 37% of men, compared to 21% with systematic biopsy alone. Combining the two approaches increases the detection rate to 41%.
Recent studies in The Journal of Nuclear Medicine have introduced new imaging techniques, including PET-based methods, to improve cancer diagnosis and treatment. Additionally, an open-source pipeline has been developed to automate tumor segmentation, and a new imaging approach has been shown to visualize therapeutic radionuclides.
Researchers developed a label-free platform combining microfluidic cell sorting with AI to enrich and identify rare CTCs. The integrated strategy uses inertial microfluidic enrichment and YOLOv8-based deep learning for bright-field image recognition, achieving 96.0% accuracy in distinguishing tumor cells.
Researchers at Kyushu University have developed a novel molecule that can produce fluorescence and serve as an MRI contrast agent, addressing limitations of current imaging techniques. The molecule, a water-soluble and metal-free compound, demonstrates improved imaging depth and reduced toxicity compared to existing agents.
Research finds accelerated brain aging in uninjured areas after stroke can predict language severity and treatment response. Brain aging patterns measured before treatment predicted improvements in language 6 months after therapy ended in patients who completed speech therapy and brain stimulation.
Recent studies published in The Journal of Nuclear Medicine have investigated new treatments for liver fibrosis, thyroid cancer, and prostate cancer, including the use of PET tracers and radioactive iodine therapy. These studies have shown promising results, including improved imaging and biochemical responses, and increased radiation ...
Researchers developed an AI model that uses routine chest CT scans to identify patients at risk of pneumonitis, a potentially life-threatening form of lung inflammation. The model, called CIPHER, achieved high predictive power and maintained strong performance despite differences in patient populations and imaging protocols.
A new study from Florida International University found that preschoolers with a higher body mass index (BMI) showed differences in brain regions involved in reward, taste, and hunger. The study suggests that the relationship between obesity risk and brain development may begin years earlier than previously thought.
New research in nuclear medicine advances detection and treatment of clear cell renal cell carcinoma with high accuracy, while SSTR antagonists show potential for imaging and treatment of neuroendocrine tumors. Alternative beta-emitting radionuclides are also being explored for targeted radiopharmaceutical therapy.
A new radiotracer, 18F-FDG PET/CT, has been shown to be highly effective in detecting rare and aggressive kidney cancer, renal medullary carcinoma (RMC). The tracer identified lesions in 98% of RMC patients and led to a change in treatment plan for 21% of patients with active disease, highlighting its potential to improve patient care.
A large-scale study found that chronic stress triggers hidden inflammation in the heart, leading to structural changes and increased risk of heart attacks and stroke. Higher levels of inflammation were associated with socioeconomic disadvantage, psychological distress, and established risk factors like smoking and excess body fat.
A targeted quality improvement campaign by University of Cincinnati emergency medicine physicians safely reduced unnecessary head and cervical spine CT scans in low-risk trauma patients, saving patients $6.2 million in healthcare costs and avoiding significant radiation exposure. The campaign, which included continuing education sessio...
A machine learning system has been developed to identify cancer cells based on their light scattering patterns, achieving high accuracy even with cells having similar morphology. The system, which uses dark-field microscopy and machine learning algorithms, has shown promise in distinguishing between different types of cancer cells.
Researchers developed targeted fecal qPCR models that showed moderate discrimination for colorectal and pancreatic cancer, offering a potential non-invasive approach for early detection and risk assessment. The study's findings suggest that fecal qPCR could provide complementary information without invasive sampling.
A study by the Medical University of Vienna shows that PSMA-PET/CT can detect 91% of clinically significant prostate cancers before biopsies, potentially preventing unnecessary procedures. The test's high detection rate and predictive value make it a promising diagnostic tool for suspected prostate cancer.
Researchers analyzed 2,826 brain MRI exams and found that individuals living in the most disadvantaged neighborhoods exhibited a higher brain age gap and lower total brain volume. This association was linked to increased risk of memory loss, cognitive problems, and dementia.
Researchers developed an automated method to convert standard eye scans into an objective cataract biomarker. The method, tested on 1906 eyes, demonstrated exceptional diagnostic discrimination and strong correlation with a standard cataract grading system.
A new review in Science Bulletin outlines how multimodal AI can integrate molecular, cellular, and clinical data to refine treatment choices and predict side effects. The approach aims to address challenges in cancer treatment, including primary resistance and immune-related adverse events.
Several new nuclear medicine approaches are being developed and evaluated for their potential to improve cancer imaging and treatment. Researchers have made significant progress in targeting specific markers and molecules in cancer cells, including CD163, CEACAM5, and DLL3. These advancements offer promising avenues for developing more...
A new study found that combining PET/MRI findings with EEG results and a structured presurgical evaluation improved the identification of seizure-causing brain tissue in pediatric epilepsy patients. 76 percent of patients who underwent surgery were free from seizures after two years of follow-up.
Babies born to anaemic mothers have smaller brain volumes, with differences detectable from 12 months old. The study found that anaemia affects brain development, particularly in regions involved in movement, learning, and communication.
Researchers developed V-UNet, a novel model combining global and local information to address noise and redundant information in medical images. The model achieved competitive segmentation performance while maintaining low computational requirements, promising a more efficient and robust AI-assisted medical image analysis.
A review led by UCLA investigators found that AI can identify subtle signs of breast cancers missed during routine mammograms, but its clinical benefit is uncertain. AI may also identify patterns associated with an increased risk of cancer before it becomes visible on a mammogram.
Researchers found that aerobic exercise alters regional brain activity patterns during cognitive tasks, while task repetition influences efficiency. In older adults, a positive correlation was observed between decline in brain activity and task performance, suggesting linked changes in task processing.
The new imaging system allows scientists to capture high-resolution fluorescence images in real time under normal room lighting, giving them a more complete picture of biological changes. SphynxVision can capture multiple images per second and reveal remarkably small details, such as tiny blood vessels and clusters of cancer cells.
A new PET/MRI technique targeting fibroblast activation protein (FAP) overexpressed in endometriosis accurately maps the extent of the disease, enabling personalized management and improving patient outcomes. The approach was particularly effective in regions of the pelvis and abdomen that are typically difficult to image.
Prostate cancer affects 1 in 8 men, with 60% diagnosed in men 65 and older. Clinical trials like Alliance's help improve early detection and treatment, reducing mortality rates by half since 1993. These trials also explore new treatments and survivorship strategies.
Researchers developed a computational model to study aging in 40 types of human tissue, identifying three major aging patterns and underlying molecular changes. Tissues show bimodal structural aging, with accelerated aging from 35-40 and 55-60, coinciding with fertility decline and menopause.
Researchers developed a dual-threshold approach for measuring tumor volume on PET/CT, showing higher total lesion volume associated with shorter overall survival and time to treatment failure. FAPI PET/CT improved detection of ovarian cancer spread, while CD8-targeted PET tracked immune response in lung cancer.
A study found that AI analysis of mammograms can identify features indicative of hypertension, ischaemic heart disease, and stroke in women. This could lead to early detection and prevention of cardiovascular diseases in midlife women who undergo routine breast cancer screening.
A study finds that dementia with Lewy bodies preferentially affects certain brain regions, including those with genes linked to mitochondrial function and synapses. These regions show distinctive patterns of serotonin, dopamine, and GABA receptors, suggesting a potential target for new treatments.
A new study from Northwestern University found that coronary calcium scans are most valuable for patients with borderline cardiovascular risk. The scans added relatively little to risk prediction from existing risk calculators, but provided a clearer picture for those at intermediate risk. The study suggests that not everyone needs a c...
The collaboration aims to advance molecular imaging research and develop new treatments for patients across the UK. Funded through charitable giving, the partnership brings together specialist radiopharmaceutical production and cutting-edge research, strengthening the UK's radiopharmaceutical research base.
USC researchers have developed custom, 3D-printed MRI sensors that provide clearer images of small organs in infants and children. The sensors, which can be customized to individual patients, are made in under 10 minutes and cost around $30.
A new study develops methods for clinicians to assess patient risk and builds an understanding of HFpEF's mechanisms, which could lead to new treatments. Researchers found potential mechanistic and molecular changes contributing to the condition.
PSMA PET/CT detected recurrent prostate cancer after minimally invasive treatments and identified malignant peripheral nerve sheath tumors with high accuracy. Researchers also found varying access to PSMA-targeted theranostics between Brazil and Europe.
Researchers at the University of Rochester have developed a lower-cost imaging system that overcomes challenges in near-infrared light transmission through deep tissue and dense fog. The AI-enhanced time-gating technique produces clearer images in these environments, improving applications such as cancer detection and LiDAR systems.
A new robotic system demonstrates superior accuracy and geometric fidelity compared to traditional methods, preserving more surrounding bone and reducing unnecessary removal. The technology has potential to make tooth autotransplantation more predictable and less dependent on operator experience.